Executive Summary
Becoming a U.S. public company is a 12- to 24-month institutional transformation, not a single filing event. Companies that treat IPO readiness as a late-stage compliance exercise consistently face delays, valuation discounts, or withdrawn offerings. Companies that treat it as an early, structured readiness program — addressing financial reporting, governance, and listing-pathway selection well before engaging underwriters — consistently execute on schedule and command stronger investor confidence at pricing.
This checklist is organized around five readiness phases: strategic foundation, financial and audit readiness, governance and compliance, team and advisory structure, and execution and filing. It is written specifically for cross-border companies — an audience most published IPO readiness guides do not address directly — and treats the choice between a Nasdaq listing and an OTC Markets pathway as a readiness variable in its own right, not an afterthought.
Introduction
Every company considering a U.S. listing eventually asks the same question: are we actually ready? The honest answer is almost always "not yet, and here is exactly what stands in the way." A structured readiness assessment converts that vague uncertainty into a concrete, sequenced plan.
This is particularly true for companies based outside the United States. Cross-border issuers face the same core requirements as domestic companies — audited financial statements, internal controls, governance frameworks, SEC disclosure — plus additional considerations: reconciling local accounting standards with U.S. GAAP or IFRS as accepted by the SEC, coordinating advisors across jurisdictions, and building a board and management structure that satisfies both home-market and U.S. governance expectations.
Background
Readiness assessments exist because the gap between a well-run private company and a compliant U.S. public company is larger than most management teams initially expect. Private companies are not required to produce SEC-standard periodic disclosures, maintain the internal control environment public reporting demands, or operate with the board independence and committee structure exchanges and investors expect. Building these capabilities takes time — often more time than the transaction timeline itself.
The listing pathway chosen materially changes which gaps matter most. A straightforward comparison: Nasdaq listings generally require a more developed governance and financial-reporting infrastructure before the process begins, given the exchange's quantitative listing standards; OTC Markets pathways offer a more accessible entry point for earlier-stage or newly cross-border companies, with the expectation that governance and reporting infrastructure continues maturing toward a potential future Nasdaq uplisting. Neither path removes the underlying readiness work — it changes the sequencing and the minimum bar to begin.
Most published readiness checklists are written for a single, generic domestic company profile and treat every reader as though the same sequence and the same gaps apply equally. In practice, a company's actual starting point — its financial reporting maturity, its home-jurisdiction accounting standards, whether it has ever worked with a PCAOB-registered auditor, and which listing pathway realistically fits its current scale — determines which of the steps below matter first. A checklist is most useful when it is read against that specific starting point, not worked through top to bottom as a uniform sequence.
Strategic Analysis
Readiness Is Path-Dependent
Most published IPO readiness frameworks assume a single destination: a large-exchange listing with underwriters, a roadshow, and a bookbuilding process. That framework does not transfer cleanly to an OTC Markets pathway, where the process, timeline, and readiness bar differ meaningfully. A company evaluating U.S. market access should determine its pathway early — informed by financial scale, governance maturity, and capital-raising objectives — since the pathway determines which readiness items are sequenced first.
Cross-Border Readiness Has Its Own Gaps
Beyond the standard checklist, cross-border companies typically need to address: alignment between home-jurisdiction financial statements and U.S.-accepted accounting standards, engagement of PCAOB-registered auditors where none previously existed, legal structuring to support U.S. securities compliance from a foreign private issuer or domestic filer position, and a governance framework that can satisfy both home-market stakeholders and U.S. public company expectations simultaneously.
The 20-Step IPO Readiness Checklist
Strategic Foundation (Steps 1–4)
Confirm the strategic case for going public — capital access, currency for M&A, liquidity, brand credibility — against realistic alternatives, including remaining private or pursuing private capital raising.
Select the listing pathway (Nasdaq or OTC Markets) based on current financial scale, governance maturity, and growth trajectory, not solely on ambition.
Develop the equity story — the specific, quantifiable value proposition that will anchor investor communications from the first advisor conversation through pricing.
Establish a realistic timeline and an internal IPO steering committee to own it, reporting directly to the board.
Financial and Audit Readiness (Steps 5–9)
Engage a PCAOB-registered audit firm and begin (or continue) audited financial statements covering the periods a registration statement will require.
Reconcile historical financial statements to U.S. GAAP or SEC-accepted IFRS, addressing any local-standard divergences early — this is frequently the single largest source of cross-border timeline slippage.
Implement financial close and reporting processes capable of meeting public-company periodic reporting deadlines, not just annual audit cycles.
Build the internal controls environment a public company audit and ongoing reporting will require.
Prepare pro forma and historical financial disclosures needed to support the registration statement and investor materials.
Governance and Compliance (Steps 10–13)
Build a board with the independence, expertise, and committee structure (audit, compensation, nominating/governance) the chosen exchange and SEC rules require.
Adopt formal corporate governance policies — codes of conduct, insider trading policies, disclosure controls — before they are required, not after.
Complete a legal and corporate structuring review, including any pre-listing reorganization or holding company formation.
Establish investor relations and disclosure protocols appropriate for a newly public company's ongoing obligations.
Team and Advisory Structure (Steps 14–16)
Assemble core advisors: securities counsel, PCAOB-registered auditors, and a strategic transaction manager coordinating the overall process.
Engage underwriters or broker-dealers appropriate to the chosen pathway and offering size.
Confirm internal management bandwidth — a public listing places real, sustained demands on the CFO and finance function specifically; understaffing here is a common cause of delay.
Execution and Filing (Steps 17–20)
Prepare and file the registration statement (for example, Form S-1 or Form F-1) with legal counsel and reporting specialists.
Respond to SEC comment letters and complete the review and amendment cycle.
Finalize pricing, listing mechanics, and — where applicable — the marketing and bookbuilding process.
Transition to public-company operating cadence: periodic SEC reporting, investor communications, and continuing governance and compliance obligations.
Practical Considerations
Sequencing matters more than speed. Attempting to compress financial-readiness and governance work into the months immediately before filing is the most common cause of delayed or withdrawn offerings. Companies that begin readiness work 12–18 months ahead of an intended filing consistently execute with fewer surprises than those that begin once underwriters are already engaged.
Cross-border companies specifically should budget additional time for accounting-standard reconciliation and for coordinating legal counsel across jurisdictions — these are frequently underestimated in generic, domestically-written readiness timelines.
Advisor sequencing matters as much as advisor selection. Engaging securities counsel and auditors before the listing pathway is fully confirmed allows their early findings to actually shape the decision, rather than validating a choice already made. Underwriters or broker-dealers, by contrast, are typically engaged later — once financial readiness and governance work are far enough along to support a credible offering timeline. Bringing them in prematurely, before the company can substantiate its readiness, tends to compress the diligence process rather than genuinely accelerate it. Coordinating this sequence across multiple advisors and, for cross-border companies, multiple jurisdictions, is precisely the kind of workstream a strategic transaction manager exists to own — someone whose job is the sequencing itself, not any single advisor's individual workstream.
Key Risks
Starting financial-statement audit work too late — audited periods cannot be compressed after the fact.
Selecting a listing pathway before assessing actual readiness against it — a mismatch between ambition and current governance/financial maturity is a leading cause of delay.
Underestimating internal control build-out — this is typically the most time-intensive readiness workstream and the easiest to underestimate.
Treating governance as a pre-listing formality rather than an operating requirement — governance built only to satisfy a listing application, without genuine board engagement, tends to surface as a weakness in ongoing public-company operations.
Frequently Asked Questions
How long does IPO readiness actually take?
Most companies need 12 to 24 months of active readiness work before filing, not counting the registration and review process itself. Companies with underdeveloped financial reporting or governance infrastructure should plan toward the longer end of that range — compressing it usually means discovering gaps after underwriters are already engaged, which is the most expensive time to find them.
Does readiness look different for a Nasdaq listing versus an OTC Markets listing?
Yes, materially. Nasdaq's quantitative listing standards mean a company generally needs more developed financial-reporting and governance infrastructure before beginning the formal process. OTC Markets pathways offer a more accessible entry point, with the expectation that infrastructure continues maturing afterward — but the underlying readiness work does not disappear, it is resequenced.
Do we need audited financial statements before starting the readiness process?
Audited financials should be one of the first workstreams, not a later one. Because audited periods cannot be produced retroactively on a compressed timeline, delays in starting the audit are one of the most common — and most avoidable — causes of a slipped filing date.
What is the most common readiness gap for cross-border companies specifically?
Reconciling home-jurisdiction financial statements to U.S.-accepted accounting standards. This is frequently underestimated because it is treated as a technical accounting task rather than a project with its own timeline, dependencies, and risk of delay — it deserves the same early planning as governance and legal structuring.
Can a company list on OTC Markets first and move to Nasdaq later?
Yes — this is a common and deliberate strategy, often referred to as an uplisting path. Companies use an OTC Markets listing to establish a U.S. public trading history and continue building governance and financial-reporting maturity, with a future Nasdaq listing as an explicit medium-term objective rather than an immediate one.
Recommendations
Begin with a formal readiness assessment against the specific pathway under consideration, not a generic checklist alone. Engage securities counsel and auditors early enough that their findings can actually influence the timeline, rather than simply documenting gaps discovered too late to address gracefully. Build the internal steering structure — and internal management bandwidth — before, not during, the transaction process. For cross-border companies, commission the accounting-standard reconciliation review as an explicit early workstream with its own owner and timeline, rather than folding it into the general audit engagement where it is easy to underestimate.
Conclusion
IPO readiness is not a document to prepare in the weeks before filing — it is an operating transformation that, done well, begins well over a year in advance and produces a company genuinely capable of operating as a public issuer, not merely one that has satisfied a listing application. For cross-border companies in particular, treating pathway selection and jurisdiction-specific readiness gaps as first-order planning questions — rather than details to resolve later — is what separates a well-executed listing from a delayed one.
Related reading: OTC vs. Nasdaq: Which U.S. Listing Path Is Right for Your Company? and Understanding SEC Registration: S-1, F-1, 20-F and 6-K Explained. See also our IPO Advisory service.
Sources: U.S. Securities and Exchange Commission — Forms Index and Nasdaq Initial Listing Guide. Verified against these primary sources August 10, 2026.
Related reading: Not ready for public markets yet, or not sure an IPO is the right path at all? See The Faster, Simpler Way to Raise Capital in the U.S. — Without Going Public.
About FMP Capital Partners
FMP Capital Partners advises growth companies on U.S. capital markets, including OTC Markets, Nasdaq listings, SEC readiness, cross-border transactions, capital raising, and investor preparedness. Our advisory approach is tailored to each company's objectives and long-term growth strategy.